Healthcare - Drug Manufacturers - Specialty & Generic - NYSE - IN
$ 14.17
-0.492 %
$ 12.2 B
Market Cap
18.17
P/E
Price Target
Average
--100.00%
Revenue Forecast
Estimate
12.47%
EBIT
Estimate
7.25%
Net Income
Estimate
--33.72%
WALL STREET ESTIMATES
Wall Street Analysts Price Targets
Dr. Reddy's Laboratories Limited
RDY has no price targets from Wall Street.
REVENUE FORECAST
Revenue Forecast Chart RDY
EBIT FORECAST
EBIT Forecast Chart RDY
NET INCOME FORECAST
Net Income Chart RDY